Skip to content

Bain Capital Life Sciences Opportunities IV GP, LLC

Follow

13F filer, CIK 2015657, Boston, MA

Bain Capital Life Sciences Opportunities IV GP, LLC filed a 13F-NT notice for the quarter ended 2026-09-30 on 2026-11-16.

Accepted , ingested 13F-NT 0001193125-26-462077

This filer reports no holdings of its own for Q3 2026. It filed a 13F-NT notice, and its holdings are in the report of . How notices are handled.

Changes against Q2 2026 are not shown: it was a notice, with the holdings in another manager's report (0 positions on file), so every position would read as new.

Part of the filer group Bain Capital Life Sciences Investors, LLC

How groups are built

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • SGRY SURGERY PARTNERS INC: 13D/A 30,055,197 shares, 22.96% of the class, 13D/A filed 2026-10-26, 0001193125-26-431228Timeline
    Accepted , ingested
  • ADCT ADC THERAPEUTICS SA: 13G 14,825,625 shares, 9.99% of the class, 13G filed 2026-10-29, 0001193125-26-438199Timeline
    Accepted , ingested

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-NT 0001193125-26-462077 notice2026-11-16